Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB-DYYB Cause Ulcer? 77 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 77 reports of Ulcer have been filed in association with INFLIXIMAB-DYYB (ZYMFENTRA). This represents 0.3% of all adverse event reports for INFLIXIMAB-DYYB.

77
Reports of Ulcer with INFLIXIMAB-DYYB
0.3%
of all INFLIXIMAB-DYYB reports
2
Deaths
37
Hospitalizations

How Dangerous Is Ulcer From INFLIXIMAB-DYYB?

Of the 77 reports, 2 (2.6%) resulted in death, 37 (48.1%) required hospitalization.

Is Ulcer Listed in the Official Label?

Yes, Ulcer is listed as a known adverse reaction in the official FDA drug label for INFLIXIMAB-DYYB.

What Other Side Effects Does INFLIXIMAB-DYYB Cause?

Off label use (14,256) Condition aggravated (10,275) Intentional product use issue (7,549) Inappropriate schedule of product administration (5,977) Arthralgia (4,615) Drug ineffective (3,112) Fatigue (3,111) Weight increased (2,848) Malaise (2,766) Weight decreased (2,703)

What Other Drugs Cause Ulcer?

ADALIMUMAB (1,368) METHOTREXATE (1,042) RITUXIMAB (880) ETANERCEPT (859) INFLIXIMAB (691) TOCILIZUMAB (665) ABATACEPT (579) LEFLUNOMIDE (561) SULFASALAZINE (515) HYDROXYCHLOROQUINE (512)

Which INFLIXIMAB-DYYB Alternatives Have Lower Ulcer Risk?

INFLIXIMAB-DYYB vs INFLIXIMAB-QBTX INFLIXIMAB-DYYB vs INFLIXIMAB, RECOMBINANT INFLIXIMAB-DYYB vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B

Related Pages

INFLIXIMAB-DYYB Full Profile All Ulcer Reports All Drugs Causing Ulcer INFLIXIMAB-DYYB Demographics